Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 9 years, D1000 Varejo Farma Participacoes's highest 3-Year average EPS without NRI Growth Rate was 534.50% per year. The lowest was -66.50% per year. And the median was 27.70% per year.
D1000 Varejo Farma Participacoes (BSP:DMVF3) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
D1000 Varejo Farma Participacoes Earnings per Share (Diluted) Related Terms
D1000 Varejo Farma Participacoes Earnings per Share (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
D1000 Varejo Farma Participacoes Earnings per Share (Diluted) Chart
D1000 Varejo Farma Participacoes Earnings per Share (Diluted) Competitor Comparison
For the Pharmaceutical Retailers subindustry, D1000 Varejo Farma Participacoes's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
D1000 Varejo Farma Participacoes PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, D1000 Varejo Farma Participacoes's PE Ratio distribution charts can be found below:
* The bar in red indicates where D1000 Varejo Farma Participacoes's PE Ratio falls into.
D1000 Varejo Farma Participacoes Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0.43
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of R$0.43 mean?
D1000 Varejo Farma Participacoes (BSP:DMVF3) has a Earnings per Share (Diluted) of R$0.43 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on D1000 Varejo Farma Participacoes and its competitors. According to the industry distribution chart, D1000 Varejo Farma Participacoes ranks #150 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 29.6%.
Is D1000 Varejo Farma Participacoes' Earnings per Share (Diluted) too high?
D1000 Varejo Farma Participacoes' current Earnings per Share (Diluted) is R$0.43. Based on the distribution chart, D1000 Varejo Farma Participacoes ranks #150 out of 507 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, D1000 Varejo Farma Participacoes has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does D1000 Varejo Farma Participacoes' Earnings per Share (Diluted) compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, D1000 Varejo Farma Participacoes ranks #150 out of 507 companies for Earnings per Share (Diluted). This puts D1000 Varejo Farma Participacoes in the upper half of its industry. The industry median Earnings per Share (Diluted) is 11.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.10, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on D1000 Varejo Farma Participacoes and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. D1000 Varejo Farma Participacoes's current Earnings per Share (Diluted) is R$0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D1000 Varejo Farma Participacoes stock overvalued right now?
Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes (BSP:DMVF3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$7.73, compared to a current price of R$6.46 — trading 16.4% below its estimated fair value. The current Earnings per Share (Diluted) is R$0.43. D1000 Varejo Farma Participacoes' overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For D1000 Varejo Farma Participacoes (BSP:DMVF3), the current Earnings per Share (Diluted) is R$0.43 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is D1000 Varejo Farma Participacoes (BSP:DMVF3) Overvalued in 2026?
Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes stock appears to be undervalued.
The current stock price of R$6.46 is trading 16.4% below its estimated GF Value™ of R$7.73.
GuruFocus considers D1000 Varejo Farma Participacoes to be Modestly Undervalued.
Key valuation signals for BSP:DMVF3:
Earnings per Share (Diluted): R$0.43
GF Value™: R$7.73 vs. price of R$6.46 (16.4% below fair value)
No single metric tells the full story. See the BSP:DMVF3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:DMVF3 has been successfully added to your 
